SINGAPORE - Two companies have merged to create Asia's first tech-based firm to offer healthcare solutions tailored to Asian women.
This focus on Asian women is important because some global standard tests for women's health have generated less precise results due to genetic differences amongst various phenotypes, the company said on Tuesday . The deal, which will create an entity valued at US$72 million, is backed by institutional investors, including multinational Genting, government agency Enterprise Singapore and investment company SNS Holdings.
The company is also developing a point of care kit called OvaCis that can distinguish benign from malignant ovarian cysts in five minutes. It is also looking into a blood-based test for the early detection of ovarian cancer and a technology that is one of the first epigenetics-based early detection tests for breast cancer in Asian women.The company plans to commercialise these technologies across Asia by 2020.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: ChannelNewsAsia - 🏆 6. / 66 続きを読む »
ソース: BusinessTimes - 🏆 15. / 51 続きを読む »